Sansure Immunological Technology Platform adopts advanced nanoparticle technology, protein labelling and modification technology, using high quality coloured latex and colloidal gold as tracers, and has developed a series of easy-to-use, highly sensitive and rapid detection products, covering SARS-CoV-2 antigen, SARS-CoV-2/InFluA/InFluB antigen, SARS-CoV-2 neutralizing antibody and other SARS-CoV-2 immunological reagents, to meet the needs of different scenarios such as home self-test, POCT and laboratory testing.

Beyond Cervical Cancer: HPV Prevention for Both Men and Women
2026-11-15

The prevention and control of Human papillomavirus (HPV)-related diseases concerns both men and women. Global burden-of-disease studies estimate that in 2018, approximately 660,000 new cancer cases in women and 72,000 in men were attributable to HPV infection, underscoring the significant public health importance of HPV prevention and control[1]. However, in China’s previous HPV prevention practice, the linkage between vaccination, screening, […]

LEARN MORE
Rethinking Adult TBM: From Diagnosis to Treatment
2026-11-09

Tuberculous meningitis (TBM) most often occurs secondary to pulmonary tuberculosis; a small proportion of cases result from hematogenous spread of lymph node or osteoarticular tuberculosis. It is the most critical subtype of tuberculosis, with an insidious onset, a high misdiagnosis rate, and extremely high risks of disability and mortality. High-risk groups include patients with active pulmonary tuberculosis, people with HIV […]

LEARN MORE
One Test, Three Viruses: Advancing HIV Screening with HBV/HCV/HIV NAT
2026-10-23

AIDS remains a major global public health challenge, and China’s prevention-and-control situation is equally serious. Under the Plan for AIDS Containment, Prevention and Treatment in China (2024–2030), China targets an HIV case-finding rate of ≥95% by 2030, yet the current rate is only 84%, and late diagnosis still accounts for as much as 38.7% — so expanding testing and optimizing […]

LEARN MORE
From ER to Primary Care: How Molecular Point-of-Care Testing Is Reshaping Tiered Diagnosis of Respiratory Infections?
2026-10-16

Recently, the Expert Consensus on Graded Testing Strategies and Tiered Application of Respiratory Pathogens (2026 Edition) [1] was officially published in the Chinese Journal of Laboratory Medicine. Led by the National Clinical Research Center for Respiratory Diseases and the Chinese Society of Laboratory Medicine, the consensus was developed by a multidisciplinary expert panel and puts forward 17 recommendations on the graded […]

LEARN MORE
Is COVID-19 Making a Comeback — or Is This Part of a Seasonal Pattern?
2026-10-10

  Recent surveillance data from the China CDC (Chinese Centre for Disease Control and Prevention) show a clear upward trend in June 2026. Across the country, 79,000 newly confirmed cases were reported during the month. Among influenza-like illness cases seen in outpatient and emergency departments, SARS-CoV-2 positivity rose from 2.9% in early June to 9.6% by early July, making it the […]

LEARN MORE
1 2 3 … 14
×
Get in touch with us
I confirm that I have reviewed Sansure's Privacy Policy and agree with the collection and storage of my personal data.
SUBMIT

Thank you!

We shall contact you soon!
Back Top